{
    "clinical_study": {
        "@rank": "11773", 
        "acronym": "SDIS", 
        "arm_group": [
            {
                "arm_group_label": "Intensive insulin treatment", 
                "description": "Intensive insulin treatment"
            }, 
            {
                "arm_group_label": "Standard insulin treatment", 
                "description": "Standard insulin treatment"
            }
        ], 
        "brief_summary": {
            "textblock": "To investigate long-term effects on cardiovascular mortality/morbidity and renal failure in\n      type 1 diabetes patients former randomized to intensive insulin treatment"
        }, 
        "brief_title": "Long-term Effects of Intensive Insulin Treatment in Type 1 Diabetes", 
        "completion_date": {
            "#text": "December 2011", 
            "@type": "Actual"
        }, 
        "condition": [
            "Coronary Heart Disease", 
            "Stroke", 
            "Renal Failure"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Coronary Artery Disease", 
                "Myocardial Ischemia", 
                "Coronary Disease", 
                "Heart Diseases", 
                "Renal Insufficiency", 
                "Stroke"
            ]
        }, 
        "detailed_description": {
            "textblock": "The Stockholm Diabetes Intervention Study (SDIS) aimed to determine whether intensified\n      insulin treatment were feasible and led to less serious diabetic complications. 102 patients\n      with type 1 diabetes mellitus were randomized (October 1982 to March 1984) to intensified\n      conventional treatment (ICT; n=48) or standard treatment (ST; n=54). The randomized SDIS\n      study lasted for 7.5 years, whereas 96 patients were fully evaluated. Thereafter patients\n      were assigned to their regular clinical visits.\n\n      In the present observational study we wanted to study all-cause mortality and cardiovascular\n      outcomes (i.e. myocardial infarction and stroke), and renal failure in the SDIS cohort until\n      december 31 2011."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Born 1930 or later\n\n          -  Type 1 diabetes\n\n          -  Nonproliferative retinopathy\n\n          -  Normal serum creatinine\n\n          -  Unsatisfactory blood glucose control\n\n        Exclusion Criteria:\n\n          -  Alcohol/drug abuse\n\n          -  Proliferative retinopathy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "52 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "A total of 102 patients with type 1 diabetes mellitus were randomised to ICT (n=48) or ST\n        (n=54) with insulin between September 1982 and March 1984. The original SDIS study lasted\n        for an average of 7.5 years and ceased in 1990, by which time 96 patients had been fully\n        evaluated. Thereafter, all patients were assigned to their regular clinical visits, mainly\n        at one hospital (S\u00f6dersjukhuset, Stockholm, Sweden)."
            }
        }, 
        "enrollment": {
            "#text": "102", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "May 9, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02138006", 
            "org_study_id": "EPN-2012"
        }, 
        "intervention": [
            {
                "arm_group_label": "Intensive insulin treatment", 
                "intervention_name": "Intensive insulin treatment", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Standard insulin treatment", 
                "intervention_name": "Standard insulin treatment", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Insulin"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 12, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Stockholm", 
                    "country": "Sweden", 
                    "zip": "11883"
                }, 
                "name": "S\u00f6dersjukhuset"
            }
        }, 
        "location_countries": {
            "country": "Sweden"
        }, 
        "number_of_groups": "2", 
        "official_title": "Stockholm Diabetes Intervention Study", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Sweden: Regional Ethical Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2011", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "All cause mortality and composite mortality from myocardial infarction, stroke and renal failure", 
            "measure": "Cardiovascular mortality", 
            "safety_issue": "No", 
            "time_frame": "Up to 28 years"
        }, 
        "reference": [
            {
                "PMID": "8147960", 
                "citation": "Reichard P, Nilsson BY, Rosenqvist U. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med. 1993 Jul 29;329(5):304-9."
            }, 
            {
                "PMID": "8772731", 
                "citation": "Jensen-Urstad KJ, Reichard PG, Rosfors JS, Lindblad LE, Jensen-Urstad MT. Early atherosclerosis is retarded by improved long-term blood glucose control in patients with IDDM. Diabetes. 1996 Sep;45(9):1253-8."
            }, 
            {
                "PMID": "3048052", 
                "citation": "Reichard P, Britz A, Cars I, Nilsson BY, Sobocinsky-Olsson B, Rosenqvist U. The Stockholm Diabetes Intervention Study (SDIS): 18 months' results. Acta Med Scand. 1988;224(2):115-22."
            }, 
            {
                "PMID": "8288056", 
                "citation": "Reichard P, Pihl M. Mortality and treatment side-effects during long-term intensified conventional insulin treatment in the Stockholm Diabetes Intervention Study. Diabetes. 1994 Feb;43(2):313-7."
            }, 
            {
                "PMID": "24802206", 
                "citation": "Rathsman B, Jensen-Urstad K, Nystr\u00f6m T. Intensified insulin treatment is associated with improvement in skin microcirculation and ischaemic foot ulcer in patients with type 1 diabetes mellitus: a long-term follow-up study. Diabetologia. 2014 May 7. [Epub ahead of print]"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02138006"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Karolinska Institutet", 
            "investigator_full_name": "Thomas Nystrom", 
            "investigator_title": "dr", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Morbidity of coronary heart disease, stroke and renal failure", 
            "measure": "Morbidity of cardiovascular complications (i.e. coronary heart disease and stroke) and renal failure", 
            "safety_issue": "No", 
            "time_frame": "Up to 28 years"
        }, 
        "source": "Karolinska Institutet", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Karolinska Institutet", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 1982", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "May 2014"
    }
}